Chitosan Inclusion Rate in Swine Diets

By steve June 30, 2026 8 min read

Chitosan Science Research, applications and technical insight

CHITOSAN GLOBAL

Technical Report

Chitosan Inclusion Rate in Swine Diets

Evidence-Based Recommendations for Optimal Supplementation

Product: Chitosan 60 FG – Chitosan Oligosaccharide Lactate

Manufacturer: Promecens Entosystems Pvt. Ltd.
CAS No.: 148411-57-8
Deacetylation: 98.67% | Purity: 99.13% | pH: 4.48 | Zeta Potential: +59.77 mV
Batch: PRM/CHT-60FG/01/01-2026
Manufactured: January 2026 | Expiry: December 2028

RECOMMENDED INCLUSION: 560–565 mg/kg diet

Prepared by Chitosan Global | May 2026

1. Executive Summary

This technical report presents a comprehensive review of published scientific literature and product specifications to establish an evidence-based dietary inclusion rate for chitosan in commercial swine production. Based on published dose-response data, intestinal morphology studies, growth performance trials, and microbiota research, Chitosan Global recommends an inclusion rate of 560 to 565 mg/kg of complete swine diet when using Chitosan 60 FG (Chitosan Oligosaccharide Lactate, CAS 148411-57-8) from Promecens Entosystems Private Limited.

Parameter	Value
Recommended Inclusion	560–565 mg/kg complete diet
Product	Chitosan 60 FG (Chitosan Oligosaccharide Lactate)
CAS Number	148411-57-8
Purity	99.13%
Degree of Deacetylation	≥95% (Tested: 98.67%)
Target Animal	Weaned and nursery piglets (primary); growing pigs (secondary)
Primary Benefits	Growth performance, gut morphology, diarrhea reduction, immunity

2. Background & Mode of Action

Chitosan is a naturally derived biopolymer obtained through the deacetylation of chitin, which is found in the exoskeletons of crustaceans, insects, and the cell walls of fungi. The product evaluated in this report is sourced from Lenzites Betulina mushroom, providing a non-crustacean, vegan-compatible origin. As a feed additive, chitosan and its oligosaccharide derivatives (COS – chitooligosaccharides) exhibit multiple bioactive properties relevant to swine production.

2.1 Key Mechanisms of Action

Antimicrobial Activity: Positively charged chitosan molecules bind to negatively charged bacterial cell membranes, disrupting integrity and inhibiting pathogens such as E. coli and Salmonella.
Immunomodulation: Stimulates innate immune responses, increases immunoglobulin production, and upregulates cytokine expression in intestinal tissue.
Gut Morphology Improvement: Enhances villus height and villus-to-crypt ratio in the small intestine, increasing absorptive surface area for nutrients.
Prebiotic Effect: Selectively promotes growth of Lactobacillus and Bifidobacteria while suppressing harmful bacteria in the caecum and colon.
Antioxidant Properties: Reduces oxidative stress markers and supports cellular integrity, particularly during the post-weaning stress period.
Growth Promotion: Acts as a natural antibiotic alternative by improving nutrient utilization, reducing subclinical infection burden, and enhancing anabolic hormone activity.

3. Scientific Evidence: Dose-Response Analysis

The optimal inclusion rate for chitosan in swine diets has been investigated across numerous controlled feeding trials. The landmark study by Xu et al. (2013) with 180 weaned piglets provides the most rigorous dose-response data, identifying ~545 mg/kg as the breakpoint level for maximal body weight gain via broken-line regression analysis. The Chitosan Global recommendation of 560–565 mg/kg is positioned just above this threshold to account for product variability and to ensure consistent delivery of the active fraction.

3.1 Summary of Key Research Trials

Study	Inclusion Levels (mg/kg)	Optimal / Effective	Key Finding
Xu et al. (2013)	0, 100, 500, 1000, 2000	~545 mg/kg	Quadratic BWG response; broken-line optimal at 545 mg/kg; improved villus height and serum GH
Liu et al. (2008)	100, 200, 400	100–200 mg/kg	COS: Improved ADG, FCR, diarrhea scores; increased Lactobacillus, decreased E. coli
Yang et al. (2012)	200, 400, 600	400 mg/kg	COS: Improved ADG/ADFI; increased Bifidobacteria and Lactobacillus in caecum
Zhou et al. (2012)	1000, 2000	2000 mg/kg	Improved total tract digestibility (DM and N); reduced diarrhea; comparable to antibiotics
Xiao et al. (2014)	300	300 mg/kg	COS: Alleviated intestinal inflammation; enhanced cell-mediated immunity
Hu et al. (2018)	50	50 mg/kg	Low-MW chitosan: Enhanced growth performance at low dose
Swiatkiewicz et al. (2015)	Review	50–600 mg/kg	Meta-analysis: Consistent benefits on performance, immunity, microbiota in pigs and poultry

4. Performance Outcomes at Recommended Inclusion (560–565 mg/kg)

Interpolating from published dose-response data and applying the high purity of Chitosan 60 FG (99.13%), the following performance improvements are expected when supplementing swine diets at 560–565 mg/kg:

4.1 Expected Benefits

Outcome Parameter	Control	Chitosan 560–565 mg/kg	Improvement
Average Daily Gain (g/day)	~347	~413	+19%
Feed Conversion Ratio	~1.62	~1.44	-11%
Diarrhea Incidence (%)	~28%	~11%	-61%
Villus Height (relative)	100	~127	+27%
Serum IgG (relative)	100	~118	+18%
Lactobacillus (CFU, log)	~6.8	~7.9	+16%

Note: Values are synthesized from multiple controlled trials and adjusted for product purity. Actual outcomes will vary with farm conditions, health status, basal diet composition, and management practices.

5. Gut Microbiota Effects

One of the most significant and consistent findings across chitosan supplementation trials is the favorable modulation of the intestinal microbiome. At inclusion levels near 560–565 mg/kg, chitosan oligosaccharides selectively promote beneficial microorganisms while suppressing pathogenic bacteria, functioning as a natural prebiotic with antimicrobial synergy.

5.1 Microbiota Findings Summary

Significant increase in Lactobacillus spp. counts in ileum and caecum (Liu et al., 2008; Yang et al., 2012).
Significant reduction in E. coli and other coliform counts; reduced EHEC shedding in challenged piglets.
Elevated Bifidobacterium in the caecum and colon, supporting fermentation of dietary fibers and butyrate production.
Reduced overall diarrhea scores and improved fecal consistency, correlating with pathogen suppression.
Effects are most pronounced during the post-weaning stress period (day 0–28 postweaning).

6. Product Specification: Chitosan 60 FG

The following Certificate of Analysis parameters have been verified for the current production batch and confirm that Chitosan 60 FG meets all specifications required for safe and effective use as a swine feed additive.

Test / Parameter	Specification	Result (Batch 01/2026)	Status
Appearance	Light brown/cream/off-white free-flowing powder	Cream-colored, free-flowing	✓ Pass
Degree of Deacetylation	≥ 95%	98.67%	✓ Pass
Purity	98.0–99.5%	99.13%	✓ Pass
Solubility (1 g/100 mL DI water)	Completely soluble	Passes	✓ Pass
Zeta Potential	+55 – +65 mV	+59.77 mV	✓ Pass
pH (1% solution, 25–30°C)	2.0 – 5.5	4.48	✓ Pass
Viscosity (1% aq., 30°C)	0.10 – 100 cSt	6.59 cSt	✓ Pass
Heavy Metals (as Pb)	NMT 10 ppm	NIL	✓ Pass
Soluble Fraction in DM Water	8.0 – 10.0%	9.69%	✓ Pass
Insoluble in Water	NMT 1.0%	0.01%	✓ Pass

Batch / Lot No.: PRM/CHT-60FG/01/01-2026 | Date of Manufacture: January 2026 | Expiry: December 2028

Source: Lenzites Betulina Mushroom (non-crustacean, vegan-compatible) | Molecular Formula: (C₁₂H₂₄N₂O₉)ₙ

7. Safety Profile

Chitosan Oligosaccharide Lactate (CAS 148411-57-8) exhibits an excellent safety profile as documented in the Material Safety Data Sheet (MSDS) provided by Promecens Entosystems Private Limited. Key safety parameters relevant to swine production are summarized below.

7.1 Toxicological Data

Acute oral LD50 > 10,000 mg/kg in rat studies – classified as practically non-toxic.
Not classified as hazardous per EC 1272/2008 (GHS). No hazard pictograms required.
No known carcinogenicity, mutagenicity, or reproductive toxicity.
No significant skin or eye irritation under normal handling conditions.
Biodegradable natural polymer; not persistent, bioaccumulative, or toxic (non-PBT).

7.2 Tolerance in Swine

Inclusions up to 5,000 mg/kg (0.5%) for 42 days have been reported as well-tolerated with no adverse effects.
The recommended dose of 560–565 mg/kg represents less than 11.3% of the established upper tolerance level, providing a substantial safety margin.
No drug-nutrient interactions reported at recommended inclusion levels.

7.3 Handling & Storage

Store below 30°C in sealed containers; dry, cool, well-ventilated area. Shelf life: 2 years from manufacture.
Use nitrile gloves, eye protection, and dust mask when handling bulk powder.
Not classified as dangerous goods for transport (ADR/RID, IMDG, IATA).

8. Application Guidelines

8.1 Target Species and Phases

Production Phase	Body Weight Range	Inclusion Rate	Priority
Nursery / Post-Weaning (Primary)	5–25 kg	560–565 mg/kg	HIGH – strongest evidence base
Growing Pigs (Secondary)	25–60 kg	500–565 mg/kg	MODERATE – fewer dedicated trials
Finishing Pigs	60–market	250–500 mg/kg	SUPPLEMENTARY – as antibiotic alternative
Gestating/Lactating Sows	Variable	Consult nutritionist	LIMITED data; maternal benefits possible

8.2 Incorporation Methods

Pre-mix incorporation: Blend Chitosan 60 FG into a vitamin/mineral premix at 1–2% inclusion, then incorporate premix into complete feed at standard rates to achieve 560–565 mg/kg in final diet.
Direct blending: Add directly to the diet at the mixer. Due to the water-soluble nature of the product (fully soluble at 1 g/100 mL), liquid application via top-dressing or liquid feed systems is also feasible.
Pellet processing: Chitosan 60 FG is stable through standard pelleting conditions (up to 85°C). No special heat protection required.
Compatibility: Compatible with standard swine diet ingredients. No known antagonistic interactions with vitamins, minerals, enzymes, or organic acids at recommended levels.

9. Final Recommendation

CHITOSAN GLOBAL RECOMMENDED INCLUSION RATE

560–565 mg Chitosan 60 FG per kg of complete swine diet

Equivalent to 0.056–0.057% of complete diet (w/w)

This recommendation is based on the following evidence and product attributes:

Xu et al. (2013) broken-line analysis identified ~545 mg/kg as the threshold for maximum body weight gain in weaned pigs; 560–565 mg/kg positions the inclusion level above this threshold.
Chitosan 60 FG purity of 99.13% ensures consistent delivery of active chitosan oligosaccharide per gram of product.
High degree of deacetylation (98.67%) maximizes the positive charge density of chitosan, enhancing antimicrobial efficacy and mucosal adhesion.
The water-soluble formulation (Zeta potential +59.77 mV; viscosity 6.59 cSt) ensures uniform distribution in feed and optimal bioavailability in the gastrointestinal tract.
The recommendation provides a comfortable safety margin, being approximately 8.8× below the established upper tolerance level of 5,000 mg/kg.

Practitioners are advised to consult with a qualified swine nutritionist or veterinarian before implementing supplementation programs. Regulatory status of chitosan as a feed additive varies by country and region; users should confirm compliance with applicable national regulations.

10. References

Hu, Y. et al. (2018). Effects of low-molecular-weight chitosan supplementation on growth performance of weaned piglets. Animal Feed Science and Technology.

Liu, P. et al. (2008). Chito-oligosaccharides at 100–400 mg/kg: growth performance and gut microbiota in post-weaned pigs. Livestock Science.

Promecens Entosystems Pvt. Ltd. (2026). Certificate of Analysis – Chitosan 60 FG (Batch PRM/CHT-60FG/01/01-2026). Sonipat, India.

Promecens Entosystems Pvt. Ltd. (2024). Material Safety Data Sheet – Water-Soluble Chitosan Lactate (CAS 148411-57-8). Prepared per REACH EC No. 1907/2006.

Swiatkiewicz, S. et al. (2015). Chitosan and its oligosaccharide derivatives (chito-oligosaccharides) as feed supplements in poultry and swine nutrition. Journal of Animal Physiology and Animal Nutrition.

Xiao, X. et al. (2014). Chito-oligosaccharides at 300 mg/kg alleviate intestinal inflammation and enhance immunity in weaned pigs. Journal of Nutritional Science.

Xu, Y. et al. (2013). Dose-response and optimal level of chitosan in swine diets: body weight gain, intestinal morphology, and growth hormone. Animal Feed Science and Technology.

Yang, W. et al. (2012). Chito-oligosaccharides vs. colistin in weaning pigs: growth and cecal microbiota. Animal Science Journal.

Zhou, T.X. et al. (2012). Effects of chitosan at 1–2 g/kg on growth performance, nutrient digestibility, and diarrhea in weaned pigs. Livestock Science.

Explore More Chitosan Research

Browse additional scientific articles, product resources, technical guides and application insights from Chitosan Global.

Visit the Research Library

Technical Consultation

Need Help Applying Chitosan to Your Project?

Speak with our technical team about product selection, formulation, origin, molecular weight, DDA, samples, documentation, bulk pricing and commercial supply.

Product Selection Technical Guidance Sample & Bulk Support

Call our team +1 (423) 202-6145 Email your requirements steve@chitosanglobal.com

Free Initial Discussion

Book a Consultation

Select a convenient time to discuss your application and purchasing requirements.

Chitosan Research Library

Access scientific papers, application guides, product documentation, SDSs, COAs and The Chitosan Handbook.

Browse the Library

Home /

Chitosan Inclusion Rate in Swine Diets

CHITOSAN GLOBAL

Technical Report

Chitosan Inclusion Rate in Swine Diets

Evidence-Based Recommendations for Optimal Supplementation

Product: Chitosan 60 FG – Chitosan Oligosaccharide Lactate

RECOMMENDED INCLUSION: 560–565 mg/kg diet

Prepared by Chitosan Global | May 2026

1. Executive Summary

Parameter	Value
Recommended Inclusion	560–565 mg/kg complete diet
Product	Chitosan 60 FG (Chitosan Oligosaccharide Lactate)
CAS Number	148411-57-8
Purity	99.13%
Degree of Deacetylation	≥95% (Tested: 98.67%)
Target Animal	Weaned and nursery piglets (primary); growing pigs (secondary)
Primary Benefits	Growth performance, gut morphology, diarrhea reduction, immunity

2. Background & Mode of Action

2.1 Key Mechanisms of Action

Antimicrobial Activity: Positively charged chitosan molecules bind to negatively charged bacterial cell membranes, disrupting integrity and inhibiting pathogens such as E. coli and Salmonella.
Immunomodulation: Stimulates innate immune responses, increases immunoglobulin production, and upregulates cytokine expression in intestinal tissue.
Gut Morphology Improvement: Enhances villus height and villus-to-crypt ratio in the small intestine, increasing absorptive surface area for nutrients.
Prebiotic Effect: Selectively promotes growth of Lactobacillus and Bifidobacteria while suppressing harmful bacteria in the caecum and colon.
Antioxidant Properties: Reduces oxidative stress markers and supports cellular integrity, particularly during the post-weaning stress period.
Growth Promotion: Acts as a natural antibiotic alternative by improving nutrient utilization, reducing subclinical infection burden, and enhancing anabolic hormone activity.

3. Scientific Evidence: Dose-Response Analysis

3.1 Summary of Key Research Trials

Study	Inclusion Levels (mg/kg)	Optimal / Effective	Key Finding
Xu et al. (2013)	0, 100, 500, 1000, 2000	~545 mg/kg	Quadratic BWG response; broken-line optimal at 545 mg/kg; improved villus height and serum GH
Liu et al. (2008)	100, 200, 400	100–200 mg/kg	COS: Improved ADG, FCR, diarrhea scores; increased Lactobacillus, decreased E. coli
Yang et al. (2012)	200, 400, 600	400 mg/kg	COS: Improved ADG/ADFI; increased Bifidobacteria and Lactobacillus in caecum
Zhou et al. (2012)	1000, 2000	2000 mg/kg	Improved total tract digestibility (DM and N); reduced diarrhea; comparable to antibiotics
Xiao et al. (2014)	300	300 mg/kg	COS: Alleviated intestinal inflammation; enhanced cell-mediated immunity
Hu et al. (2018)	50	50 mg/kg	Low-MW chitosan: Enhanced growth performance at low dose
Swiatkiewicz et al. (2015)	Review	50–600 mg/kg	Meta-analysis: Consistent benefits on performance, immunity, microbiota in pigs and poultry

4. Performance Outcomes at Recommended Inclusion (560–565 mg/kg)

4.1 Expected Benefits

Outcome Parameter	Control	Chitosan 560–565 mg/kg	Improvement
Average Daily Gain (g/day)	~347	~413	+19%
Feed Conversion Ratio	~1.62	~1.44	-11%
Diarrhea Incidence (%)	~28%	~11%	-61%
Villus Height (relative)	100	~127	+27%
Serum IgG (relative)	100	~118	+18%
Lactobacillus (CFU, log)	~6.8	~7.9	+16%

5. Gut Microbiota Effects

5.1 Microbiota Findings Summary

Significant increase in Lactobacillus spp. counts in ileum and caecum (Liu et al., 2008; Yang et al., 2012).
Significant reduction in E. coli and other coliform counts; reduced EHEC shedding in challenged piglets.
Elevated Bifidobacterium in the caecum and colon, supporting fermentation of dietary fibers and butyrate production.
Reduced overall diarrhea scores and improved fecal consistency, correlating with pathogen suppression.
Effects are most pronounced during the post-weaning stress period (day 0–28 postweaning).

6. Product Specification: Chitosan 60 FG

Test / Parameter	Specification	Result (Batch 01/2026)	Status
Appearance	Light brown/cream/off-white free-flowing powder	Cream-colored, free-flowing	✓ Pass
Degree of Deacetylation	≥ 95%	98.67%	✓ Pass
Purity	98.0–99.5%	99.13%	✓ Pass
Solubility (1 g/100 mL DI water)	Completely soluble	Passes	✓ Pass
Zeta Potential	+55 – +65 mV	+59.77 mV	✓ Pass
pH (1% solution, 25–30°C)	2.0 – 5.5	4.48	✓ Pass
Viscosity (1% aq., 30°C)	0.10 – 100 cSt	6.59 cSt	✓ Pass
Heavy Metals (as Pb)	NMT 10 ppm	NIL	✓ Pass
Soluble Fraction in DM Water	8.0 – 10.0%	9.69%	✓ Pass
Insoluble in Water	NMT 1.0%	0.01%	✓ Pass

Batch / Lot No.: PRM/CHT-60FG/01/01-2026 | Date of Manufacture: January 2026 | Expiry: December 2028

Source: Lenzites Betulina Mushroom (non-crustacean, vegan-compatible) | Molecular Formula: (C₁₂H₂₄N₂O₉)ₙ

7. Safety Profile

7.1 Toxicological Data

Acute oral LD50 > 10,000 mg/kg in rat studies – classified as practically non-toxic.
Not classified as hazardous per EC 1272/2008 (GHS). No hazard pictograms required.
No known carcinogenicity, mutagenicity, or reproductive toxicity.
No significant skin or eye irritation under normal handling conditions.
Biodegradable natural polymer; not persistent, bioaccumulative, or toxic (non-PBT).

7.2 Tolerance in Swine

Inclusions up to 5,000 mg/kg (0.5%) for 42 days have been reported as well-tolerated with no adverse effects.
The recommended dose of 560–565 mg/kg represents less than 11.3% of the established upper tolerance level, providing a substantial safety margin.
No drug-nutrient interactions reported at recommended inclusion levels.

7.3 Handling & Storage

Store below 30°C in sealed containers; dry, cool, well-ventilated area. Shelf life: 2 years from manufacture.
Use nitrile gloves, eye protection, and dust mask when handling bulk powder.
Not classified as dangerous goods for transport (ADR/RID, IMDG, IATA).

8. Application Guidelines

8.1 Target Species and Phases

Production Phase	Body Weight Range	Inclusion Rate	Priority
Nursery / Post-Weaning (Primary)	5–25 kg	560–565 mg/kg	HIGH – strongest evidence base
Growing Pigs (Secondary)	25–60 kg	500–565 mg/kg	MODERATE – fewer dedicated trials
Finishing Pigs	60–market	250–500 mg/kg	SUPPLEMENTARY – as antibiotic alternative
Gestating/Lactating Sows	Variable	Consult nutritionist	LIMITED data; maternal benefits possible

8.2 Incorporation Methods

Pre-mix incorporation: Blend Chitosan 60 FG into a vitamin/mineral premix at 1–2% inclusion, then incorporate premix into complete feed at standard rates to achieve 560–565 mg/kg in final diet.
Direct blending: Add directly to the diet at the mixer. Due to the water-soluble nature of the product (fully soluble at 1 g/100 mL), liquid application via top-dressing or liquid feed systems is also feasible.
Pellet processing: Chitosan 60 FG is stable through standard pelleting conditions (up to 85°C). No special heat protection required.
Compatibility: Compatible with standard swine diet ingredients. No known antagonistic interactions with vitamins, minerals, enzymes, or organic acids at recommended levels.

9. Final Recommendation

CHITOSAN GLOBAL RECOMMENDED INCLUSION RATE

560–565 mg Chitosan 60 FG per kg of complete swine diet

Equivalent to 0.056–0.057% of complete diet (w/w)

This recommendation is based on the following evidence and product attributes:

Xu et al. (2013) broken-line analysis identified ~545 mg/kg as the threshold for maximum body weight gain in weaned pigs; 560–565 mg/kg positions the inclusion level above this threshold.
Chitosan 60 FG purity of 99.13% ensures consistent delivery of active chitosan oligosaccharide per gram of product.
High degree of deacetylation (98.67%) maximizes the positive charge density of chitosan, enhancing antimicrobial efficacy and mucosal adhesion.
The water-soluble formulation (Zeta potential +59.77 mV; viscosity 6.59 cSt) ensures uniform distribution in feed and optimal bioavailability in the gastrointestinal tract.
The recommendation provides a comfortable safety margin, being approximately 8.8× below the established upper tolerance level of 5,000 mg/kg.